Generational Equity has acted as adviser to MediSuite, on it’s acquisition by ADDvise Group AB. The deal closed on 4 August, 2021.
Located in Cary, North Carolina, MediSuite is a national, mail-order pharmacy, MediSuite provides men’s health generic drugs at significant cost savings. MediSuite only dispenses FDA-approved pharmaceuticals. MediSuite’s most popular drugs are the generics of Viagra (Sildenafil) and Cialis (Tadalafil).
ADDvise Group AB, (ADDvise) headquartered in Stockholm, Sweden is a leading supplier of equipment and services to healthcare and research facilities. The Group’s subsidiaries are organised into two business areas: LAB and HEALTHCARE. Sales are global. The Group has a clear acquisition strategy of increasing shareholder value through growth – both geographically and by product range. ADDvise shares are listed on Nasdaq First North Growth Market.
MediSuite will be consolidated into ADDvise’s financial reporting as of August 2021. The local management of MediSuite and its operational business structure will remain unchanged pursuant to ADDvise’s decentralised structure and the corporate governance of the group. ADDvise welcomes MediSuite to the group.
Generational Equity Executive Managing Director, M&A-Technology Practice Leader, David Fergusson, and his team led by Senior M&A Advisor, Gene Gall, with the support of Vice President Mergers & Acquisitions, Alex Mironov, successfully closed the deal. Executive Managing Director, Bill Kushnir established the initial relationship with MediSuite.
“MediSuite is licensed in 48 states and the District of Columbia which gives ADDvise Group a perfect launching platform for their healthcare division in the United States,” says Gall.
